Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Respiratory Immune Responses in Human Influenza Virus Infection Across Age to Understand What Dictates Disease Severity

NCT06401720 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06401720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Respiratory Immune Responses in Human Influenza Virus Infection Across Age to Understand What Dictates Disease Severity
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 1, 2024
Completion date
December 31, 2030
Enrollment
800 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

influenza a infection, influenza b virus infection, rsv infection, sars cov 2 infection